A Retrospective Study of Endoscopic Postoperative Recurrence Promotes Endoscopic Remission of Ustekinumab and Vedolizumab in Crohn's Disease
Latest Information Update: 21 Dec 2021
At a glance
- Drugs Ustekinumab (Primary) ; Vedolizumab (Primary) ; Immunomodulators; Steroids
- Indications Crohn's disease; Inflammatory bowel diseases
- Focus Therapeutic Use
- 21 Dec 2021 New trial record
- 27 Oct 2021 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2021